Platelet-to-albumin ratio is a potential biomarker for predicting diabetic nephropathy in patients with type 2 diabetes

Shi-Lu Cao,Guo-Qing Zhang,Jing Li,Li Bao,Xiao-Mei Lan,Quan-Peng Jin,Hong-Yan Luo,Jing E,Bo Li,Danna Ma,Xi Bao,Ya-Li Zheng
DOI: https://doi.org/10.2217/bmm-2023-0527
2024-01-06
Biomarkers in Medicine
Abstract:Aim: To evaluate whether platelet-to-albumin ratio (PAR) can predict diabetic nephropathy (DN) in type 2 diabetes mellitus (T2DM). Materials & methods: A total of 140 patients with T2DM and 40 healthy individuals were enrolled retrospectively. T2DM patients were divided into three groups based on the urinary albumin-to-creatinine ratio, PAR was compared and receiver operating characteristic curve was constructed to evaluate the predictive value of PAR in DN in T2DM. Results: There was a significant increase of PAR in DN among T2DM patients and PAR was positively correlated with serum creatinine, retinol-conjugated protein and β 2 -microglobulin. Moreover, PAR was a risk factor for DN in T2DM patients, which predicted DN in T2DM with high sensitivity and specificity. Conclusion: PAR can be a potential candidate to predict DN in T2DM.
medicine, research & experimental
What problem does this paper attempt to address?